The approval of a second thrombolytic for ischemic stroke raises the question of whether there are patient characteristics or circumstances that would make one drug a better choice than the other. Medscape Neurology
The approval of a second thrombolytic for ischemic stroke raises the question of whether there are patient characteristics or circumstances that would make one drug a better choice than the other. Medscape Neurology